Document Detail


Effect of methotrexate on tubal epithelium. A report of three cases.
MedLine Citation:
PMID:  9987739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Tubal effects of methotrexate injections have been poorly reported. CASES: Three fallopian tubes were examined with light microscopy 9-13 months after tubal methotrexate injection (one case) and intramuscular methotrexate injection (two cases) given for the treatment of unruptured ectopic pregnancies. No evidence of tubal damage was found. CONCLUSION: These three cases confirm previous experimental and clinical data showing the absence of a direct adverse effect of methotrexate on the fallopian tubes in the treatment of ectopic pregnancy.
Authors:
F Lécuru; F Robin; R Taurelle; J P Bernard; F Vildé
Related Documents :
12198869 - Changes in alveolar morphology during open bite treatment and prediction of treatment r...
1430949 - Efficacy of immobilization following aspiration of carpal and digital ganglions.
7499009 - Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
17267889 - Diagnosis and management of hepatic ectopic pregnancy.
15190729 - Using hypnosis to facilitate resolution of psychogenic excoriations in acne excoriée.
22223909 - Anaesthetic management for emergency caesarean section in a patient with an untreated r...
14964459 - Pregnancy in membranous glomerulonephritis--course, treatment and outcome.
9065169 - Fetal heart rate patterns in growth-restricted fetal sheep induced by chronic fetal pla...
5316259 - Structure of natural foci of zoonotic cutaneous leishmaniasis and its relationship to r...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  44     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-04-29     Completed Date:  1999-04-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  46-8     Citation Subset:  IM    
Affiliation:
Gynecologic and Obstetric Service, Boucicaut Hospital, Paris, France. fabrice.lecuru@bcc.ap-hop-paris.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage,  pharmacology*,  therapeutic use
Adult
Epithelium / drug effects
Fallopian Tubes / drug effects*,  pathology
Female
Humans
Injections, Intramuscular
Laparoscopy
Methotrexate / administration & dosage,  pharmacology*,  therapeutic use
Pregnancy
Pregnancy, Tubal / drug therapy*
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors and outcomes associated with nuchal cord. A population-based study.
Next Document:  Malignant hemangioendothelioma presenting as multifocal intraskeletal lesions during pregnancy. A ca...